Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant development program.
January 31, 2025. More for You ...
"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...
The Trump administration faces a significant challenge: millions of unauthorized flavored tobacco and vapor products continue ...
Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI ...
The White House launched a new cybersecurity safety label, the U.S. Cyber Trust Mark, intended to help consumers make informed decisions on smart device safety.
© 2025 NBCUniversal Media, LLCApple®, Apple logo® and App Store® are registered trademarks of Apple Inc.
A Texas federal judge Thursday ruled Idaho, Kansas and Missouri can join a case challenging access to the abortion pill.
Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes ...
An archived copy of the webcast will be available for up to one year by visiting the “Investors & Media” section of the 4DMT website: https://ir.4dmoleculartherapeutics.com/events.
Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...